The MAIA trial: Protocol of a prospective randomized controlled trial to evaluate the impact of an omega-3 polyunsaturated fatty acids-enriched diet on the loss of independence in nursing home residents
Abstract
BACKGROUND
Malnutrition and frailty are prevalent issues in nursing homes, leading to increased dependence and morbidity. N-3 polyunsaturated fatty acids (PUFAs), i.e. linolenic, eicosapentaenoic, and docosahexaenoic acids, have demonstrated potential benefits in mitigating inflammation, cognitive decline, and sarcopenia. However, there is limited evidence on the impact of dietary n-3 PUFAs enrichment in preventing independence loss in the older patients and particularly nursing home (NH) residents.
OBJECTIVES
The trial aims to evaluate whether an n-3 PUFAs-enriched diet to cover the recommended daily allowance needs can slow down the decline in independence among older residents in NH.
METHODS
A prospective, randomized, controlled, open-label, multicenter trial will be conducted in NH. The study population (n = 432) will be cluster-randomized into two groups: 1- an intervention group receiving an n-3 PUFAs enriched diet, and 2- a control group receiving the usual institutional diet. The primary outcome will be the change in independence, measured by the Activities of Daily Living-Long Form Score (ADL-LFS) at 24 months. Secondary outcomes will include ADL-LFS at 6, 12, and 18 months, nutritional status, body composition, muscle function, fall incidence, infection rates, cognitive function, depression scale, n-3 and n-6 PUFAs blood levels, and healthcare resource utilization. In a subgroup of patients (n = 30 per group), data on actimetry will be collected. Statistical…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 432 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.